Literature DB >> 4582435

Protective efficacy of killed Mycoplasma pneumoniae vaccine measured in large-scale studies in a military population.

W J Mogabgab.   

Abstract

Mesh:

Substances:

Year:  1973        PMID: 4582435     DOI: 10.1164/arrd.1973.108.4.899

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


× No keyword cloud information.
  6 in total

1.  Evaluation of Chlamydia pneumoniae and Mycoplasma pneumoniae as etiologic agents of persistent cough in adolescents and adults.

Authors:  Robert M Wadowsky; Elias A Castilla; Stella Laus; Anita Kozy; Robert W Atchison; Lawrence A Kingsley; Joel I Ward; David P Greenberg
Journal:  J Clin Microbiol       Date:  2002-02       Impact factor: 5.948

2.  Immunisations.

Authors:  M A Downham
Journal:  Br Med J       Date:  1976-05-01

Review 3.  Infectious diseases: annual review of significant publications.

Authors:  H A Reimann
Journal:  Postgrad Med J       Date:  1974-08       Impact factor: 2.401

4.  Demonstration of antibodies to Mycoplasma pneumoniae attachment protein in human sera and respiratory secretions.

Authors:  P C Hu; C H Huang; A M Collier; W A Clyde
Journal:  Infect Immun       Date:  1983-07       Impact factor: 3.441

Review 5.  Mycoplasma pneumoniae Infections: Pathogenesis and Vaccine Development.

Authors:  Zhulin Jiang; Shuihong Li; Cuiming Zhu; Runjie Zhou; Polly H M Leung
Journal:  Pathogens       Date:  2021-01-25

Review 6.  Applying Immune Instincts and Maternal Intelligence from Comparative Microbiology to COVID-19.

Authors:  Nevio Cimolai
Journal:  SN Compr Clin Med       Date:  2020-11-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.